01 1Zydus Lifesciences
01 1PREGABALIN USP (PROCESS II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-04-06
Pay. Date : 2018-02-16
DMF Number : 32520
Submission : 2018-02-28
Status : Active
Type : II
20
Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PREGABALIN USP (PROCESS II), with a corresponding US DMF Number 32520.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 06, 2018, and payment made on February 16, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
